FATE THERAPEUTICS INC (FATE) › Operating Cash FlowFATE THERAPEUTICS INC (FATE) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$29.82M2017: -$36.82M2018: -$38.65M2019: -$83.17M2020: -$39.23M2021: -$162.87M2022: -$248.21M2023: -$132.26M2024: -$122.87M2025: -$106.08M-$106.08M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$106.08M+13.7%2024-$122.87M+7.1%2023-$132.26M+46.7%2022-$248.21M-52.4%2021-$162.87M-315.2%2020-$39.23M+52.8%2019-$83.17M-115.2%2018-$38.65M-5.0%2017-$36.82M-23.5%2016-$29.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share